- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Norland rebounds and sells bone system
New York-based Norland Medical Systems, a bone densitometry vendor, appears to have rebounded from the dramatic fourth quarter and year-end losses of 1998. In 1999, the company’s revenue increased by 24%. Revenue for year-end 1999 was $17.8 million,
New York-based Norland Medical Systems, a bone densitometry vendor, appears to have rebounded from the dramatic fourth quarter and year-end losses of 1998. In 1999, the companys revenue increased by 24%. Revenue for year-end 1999 was $17.8 million, compared with $14.4 million in 1998.
Norlands net loss for the fourth quarter of 1999 was $791,000, compared to $4.3 million in the fourth quarter of 1998. CEO Reynald G. Bonmati attributes the firms recent success to cutting losses and positioning the company as a broader medical device vendor.
The company develops, manufactures, sells, and services a wide range of systems used to assess bone mineral content and density, the measurements used by physicians to diagnose and monitor bone disorders such as osteoporosis.
At the same time Norland announced positive news about its financial performance, company officials said they have started selling McCues CubaClinical, an ultrasound bone measurement system. In January, Norland received premarket approval from the Food and Drug Administration for this system (SCAN 2/2/00). The company obtained exclusive distribution rights for the product from McCue last June.
In March, Norland began marketing the McCue system to physicians across the U.S. The company is already distributing the system in Europe, Africa, the Middle East, and the Pacific Rim.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
